IMDx VanR Assay for Abbott MDx System Cleared in Canada, Singapore | GenomeWeb

NEW YORK (GenomeWeb News) — IMDx said today that its IMDx VanR assay for the Abbott m2000 platform has received regulatory clearance from Health Canada and Singapore's Health Sciences Authority, allowing the test to be sold and distributed in those countries.

The assay detects the presence of vanA and vanB genes that can be associated with vancomycin-resistant enterococci. It is intended to be used as an aid to identify, prevent, and control vancomycin-resistant colonization in healthcare settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece appearing in Newsday likens familial DNA search to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.

Startup companies are taking on personalized medicine, CNET reports.